Home » Stocks » ELTP

Elite Pharmaceuticals, Inc. (ELTP)

Stock Price: $0.0495 USD -0.0005 (-1.00%)
Updated Jul 28, 2021 10:52 AM EDT - Market open
Market Cap 50.46M
Revenue (ttm) 25.38M
Net Income (ttm) 5.09M
Shares Out 1.01B
EPS (ttm) 0.01
PE Ratio 9.90
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 28
Last Price $0.0495
Previous Close $0.0500
Change ($) -0.0005
Change (%) -1.00%
Day's Open 0.0470
Day's Range 0.0470 - 0.0500
Day's Volume 86,004
52-Week Range 0.0400 - 0.0900

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Conference Call Scheduled for Tuesday, June 15 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 14, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company')(OTCBB:ELTP), a specialty pharmaceutical...

1 month ago - Accesswire

Financials for Fiscal Year Ended March 31, 2021 will be released June 14, 2021 NORTHVALE, NJ / ACCESSWIRE / June 8, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company') (OTCBB:ELTP), a specialt...

1 month ago - Accesswire

NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ("Prasco"), has lau...

2 months ago - Accesswire

NORTHVALE, NJ / ACCESSWIRE / April 29, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products,...

2 months ago - Accesswire

NORTHVALE, NJ / ACCESSWIRE / January 5, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products...

6 months ago - Accesswire

About ELTP

Elite Pharmaceuticals, Inc. engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Hydromorphone HCl 8mg tablets fo... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Jul 23, 1998
Stock Exchange
OTCMKTS
Ticker Symbol
ELTP
Full Company Profile

Financial Performance

Financial Statements